Attention-deficit/hyperactivity disorder in India: epidemiology, diagnostic inequities, treatment gaps, and public mental health implications - Scorecard - MDSpire
Advertisement
Attention-deficit/hyperactivity disorder in India: epidemiology, diagnostic inequities, treatment gaps, and public mental health implications
Clinical Scorecard: Epidemiology, Diagnostic Disparities, Treatment Shortcomings, and Public Health Consequences of Attention-Deficit/Hyperactivity Disorder in India
At a Glance
Category
Detail
Condition
Key Mechanisms
Dysregulation of catecholaminergic neurotransmission, particularly dopamine and norepinephrine, is central to ADHD pathophysiology.
Target Population
Care Setting
Key Highlights
ADHD prevalence in children aged 3–12 years is estimated at 7.6%, and 5.6% in adolescents aged 12–18 years, based on Salari et al. (2023).
ADHD is under-diagnosed in India due to gaps in awareness and access to specialized interventions, as highlighted by Pandey et al.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Regular follow-ups to assess treatment efficacy and adjust interventions as necessary.
Risks
Patient & Prescribing Data
Children and adolescents with ADHD in India.
Access to specialist evaluation and treatment remains uneven, particularly in rural areas.
Clinical Best Practices
Support context-specific research to address ADHD outcomes, including studies on cultural perceptions of ADHD.
